Evidence map›Paper›PMID 41716347›Full record

ArticleMaterials today. Bio2026

Self-passivated bilayer black phosphorus QDs based multifunctional nanoparticles for tumor immune reprogramming.

Tingting Liu, Wenyan She, Ruili Du, Yali Bao, Zhibin Guo, Qichao Gao, Hanping Li, Pengfei Suo, Yi Liu, Yujiao Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tingting LiuState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Wenyan SheSchool of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, PR China.
Ruili DuState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Yali BaoState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Zhibin GuoState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Qichao GaoState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Hanping LiState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Pengfei SuoTechnology Department, Long Xun Kuang Teng Inc. Beijing, Beijing, 100192, PR China.
Yi LiuState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.
Yujiao LiuState Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Material Science and Engineering & School of Chemical Engineering and Technology, Tiangong University, Tianjin, 300387, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is important yet challenging to enhance immunotherapy responses using biosafe agents due to the immunosuppressive tumor microenvironment. To address this challenge, BD3PP was constructed by encapsulating black phosphorus quantum dots (BPQDs), a synthesized thioredoxin reductase inhibitor 3c, and Dir (the fluorescent dye) into PLGA nanoparticles, followed by conjugation with a PDL1 antagonist for synergistic multimodal therapy and imaging. The mechanism and efficiency of BD3PP were investigated through density functional theory (DFT) calculations, molecular docking, and

Indexed as

Black phosphorus quantum dotsDensity functional theoryImmunotherapyPD1Photodynamic therapy

Identifiers

PMID41716347
PMCPMC12914194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.